emd 53998 has been researched along with Chronic Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clarke, SB; Drake-Holland, AJ; Hynd, J; Lee, JA; Noble, MI | 1 |
| Duncker, DJ; Haitsma, DB; Heins, N; Liem, DA; Stubenitsky, R; Verdouw, PD | 1 |
2 other study(ies) available for emd 53998 and Chronic Disease
| Article | Year |
|---|---|
Beneficial effect of the calcium-sensitizing drug EMD 57033 in a canine model of dilated heart failure.
Topics: Animals; Blood Pressure; Cardiac Output; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Cardiotonic Agents; Chronic Disease; Dogs; Echocardiography, Transesophageal; Quinolines; Statistics, Nonparametric; Thiadiazines; Ventricular Pressure | 1997 |
Beneficial effects of the Ca2+ sensitizer EMD 57033 in exercising pigs with infarction-induced chronic left ventricular dysfunction.
Topics: Animals; Calcium; Cardiotonic Agents; Chronic Disease; Exercise Test; Female; Hemodynamics; Male; Myocardial Infarction; Pyridazines; Quinolines; Swine; Thiadiazines; Ventricular Dysfunction, Left | 2001 |